Remedent Announces Conference Call to Be Held on Tuesday, November 20, 2012 at 9 AM EST to Give an Update on Recent Strategic...
November 16 2012 - 8:50AM
Marketwired
Remedent, Inc. (OTCBB: REMI), an international company specializing
in research, development, and the manufacturing of oral care and
cosmetic products, announced today that it will host a conference
call on Tuesday, November 20, to update investors on the recent
strategic developments.
Conference Call Information:
Remedent will host a conference call on Tuesday, November 20,
2012 at 9:00 a.m. Eastern Standard Time (6:00 a.m. Pacific Standard
Time) to discuss its strategic plans for the future. A question and
answer session will follow the presentation.
To participate in this call, dial the appropriate number 5-10
minutes prior to the start time. Date: Tuesday, November 20, 2012
Time: 9:00 a.m. Eastern Standard Time. (6:00 a.m. Pacific Standard
Time) Dial in Number: 888-481-2844
A telephone replay of the call will be available until December
4, 2012. Toll Free Replay Number: 888-203-1112 Replay Password:
2439162
About Remedent Remedent, Inc. specializes
in the research, development, manufacturing and marketing of oral
care and cosmetic dentistry products. The company serves
professional dental industry with breakthrough technology for
dental veneers. These products are supported by a line of
professional veneer whitening and teeth sensitivity solutions.
Headquartered in Belgium, Remedent distributes its products to more
than 28 countries worldwide. For more information, go to
www.remedent.com.
Forward-Looking Statements Statements in
this press release that are "forward-looking statements" are based
on current expectations and assumptions that are subject to risks
and uncertainties. Such forward-looking statements involve known
and unknown risks, uncertainties and other unknown factors that
could cause Remedent's actual operating results to be materially
different from any historical results or from any future results
expressed or implied by such forward-looking statements. In
addition to statements that explicitly describe these risks and
uncertainties, readers are urged to consider statements that
contain terms such as "believes," "belief," "expects," "expect,"
"intends," "intend," "anticipate," "anticipates," "plans," "plan,"
"projects," "project," to be uncertain and forward-looking. Actual
results could differ materially because of factors such as
Remedent's ability to achieve the synergies and value creation
contemplated by the proposed transaction. For further information
regarding risks and uncertainties associated with Remedent's
business, please refer to the risk factors described in Remedent's
filings with the Securities and Exchange Commission, including, but
not limited to, its annual report on Form 10-K and quarterly
reports on Form 10-Q. We undertake no duty to revise or update any
forward-looking statements to reflect events or circumstances after
the date of this press release.
Remedent +32.9.241.58.80
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024